New Password Request

      © 2024 FinThrive, Inc. and its affiliates and subsidiaries (collectively, “FinThrive")" - All Rights Reserved

      Version: 2024.10.21.2 ClearIQ - Patent Pending

      Outpatient Evaluation - Patent Pending

      FinThrive does not provide medical advice, diagnosis, or treatment advice. The information provided is based on historical medical information obtained from the Provider. Providers are responsible for determining appropriate diagnosis/treatment options.

      * HFMA staff and volunteers determined that this product has met specific criteria developed under the HFMA Peer Review Process. HFMA does not endorse or guaranty the use of this product.

      CPT only © 2024 American Medical Association.  All rights reserved.  CPT is a registered Trademark of the American Medical Association.

      Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT®, and the AMA is not recommending their use.

      The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

      Build: 2024.10.21.2

      Site ID: 5727

      azrvpciqweb03 Emanuel Medical/Quadax

      Auth Ticket Expires:

      f2if2uwjve3tienvpnc5gvg3

      Style Guide

      U.S. Government Rights

      This product includes CPT® which is commercial technical data and/or computer data bases and/or commercial computer software and/or commercial computer software documentation, as applicable, which was developed exclusively at private expense by the American Medical Association, 515 North State Street, Chicago, Illinois, 60610. U.S. Government rights to use, modify, reproduce, release, perform, display, or disclose these technical data and/or computer data bases and/or commercial computer software and/or commercial computer software documentation are subject to the limited rights restrictions of DFARS 252.227-7015(b)(2) (November 1995) and/or subject to the restrictions of DFARS 227.7202-1(a) (June 1995), as applicable, for U.S. Department of Defense procurements and the limited rights restrictions of FAR 52.227-14 (June 1987) and/or subject to the restricted rights provisions of FAR 52.227-14 (June 1987) and FAR 52.227-19 (June 1987), as applicable, and any applicable agency FAR Supplements, for non-Department of Defense Federal procurements.